Pharmacokinetic-pharmacodynamic studies of the 11β-hydroxysteroid dehydrogenase type 1 inhibitor MK-0916 in healthy subjects.
Wright DH, Stone JA, Crumley TM, Wenning L, Zheng W, Yan K, Yang AY, Sun L, Cilissen C, Ramael S, Hermanowski-Vosatka A, Langdon RB, Gottesdiener KM, Wagner JA, Lai E.
Wright DH, et al. Among authors: sun l.
Br J Clin Pharmacol. 2013 Dec;76(6):917-31. doi: 10.1111/bcp.12131.
Br J Clin Pharmacol. 2013.
PMID: 23594227
Free PMC article.
Clinical Trial.